Evidence map›Paper›PMID 35953513›Full record

SynthesisPediatric research2023

Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597 children with diabetes.

Anas Elgenidy, Ahmed K Awad, Khaled Saad, Mostafa Atef, Hatem Helmy El-Leithy, Ahmed A Obiedallah, Emad M Hammad, Faisal-Alkhateeb Ahmad, Ahmad M Ali, Hamad Ghaleb Dailah and 2 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Pediatric research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Covid 19 and diabetes in children: advances and strategies.Diabetology & metabolic syndrome · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anas Elgenidy *Faculty of Medicine, Cairo University, Cairo, Egypt.
Ahmed K Awad *Ain Shams University Faculty of Medicine, Cairo, Egypt.
Khaled SaadPediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt. khaled.ali@med.au.edu.eg.ORCID http://orcid.org/0000-0002-8473-6116
Mostafa AtefFaculty of Medicine, Cairo University, Cairo, Egypt.
Hatem Helmy El-LeithyFaculty of Medicine, Cairo University, Cairo, Egypt.
Ahmed A ObiedallahDepartment of Internal Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt.
Emad M HammadPediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Faisal-Alkhateeb AhmadPediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Ahmad M AliPediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Hamad Ghaleb DailahResearch and Scientific Studies Unit, College of Nursing, Jazan University, Jazan, Saudi Arabia.
Amira ElhoufeyDepartment of Community Health Nursing, Faculty of Nursing, Assiut University, Assiut, Egypt.
Samaher Fathy TahaPediatric Department, Faculty of Medicine, Assiut University, Assiut, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic ketoacidosis (DKA) is a potentially life-threatening complication of type 1 diabetes mellitus (T1DM) that has increased during the COVID-19 pandemic. This study will not only shed light on such life-threatening complications but also be a step to increase the awareness of healthcare providers about such complications in the upcoming pandemic waves and increased dependence on telemedicine. Thus, we aimed to further investigate the increase of DKA in pediatrics.

methodsPubMed, Web of Science, and Scopus were broadly searched for studies assessing the incidence of DKA in pediatrics during the COVID-19 pandemic.

resultsOur study included 24 papers with a total of 124,597 children with diabetes. A statistically significant increase occurred in the risk of DKA among newly diagnosed T1DM patients during the pandemic (RR 1.41; 95% CI 1.19, 1.67; p < 0.01; I

conclusionDKA in newly diagnosed children with T1DM has increased during the pandemic and presented with a severe form. This may reflect that COVID-19 may have contributed not only to the development but also the severity of DKA. IMPACT: Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM) that has increased during the COVID-19 pandemic. Our study included 25 papers with a total of 124,597 children with diabetes. A statistically significant increase occurred in the risk of DKA among newly diagnosed T1DM patients during the pandemic. Our findings reflect that COVID-19 may have an altered presentation in T1DM and can be related to DKA severity.

Indexed as

COVID-19Diabetes Mellitus, Type 1Diabetic KetoacidosisChildHumansIncidencePandemicsRetrospective StudiesSeverity of Illness Index

Identifiers

PMID35953513
PMCPMC9366798

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.